In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ravi Patel

Advertisement
Set Alert for Articles By Ravi Patel

Latest From Ravi Patel

Companion Diagnostics: The Expanding Reach Of Personalized Medicine

Personalized medicine is becoming the hallmark of care in oncology, but its use is also increasing in other therapeutic areas including inflammation, respiratory, infectious diseases and central nervous system disorders, as scientific understanding of these diseases advances. The expansion of companion diagnostics beyond oncology has impacts on dealmaking, clinical practice and the R&D pipeline.

Personalized Medicine Innovation

Survey Points To Biomarkers’ Emerging Role In Clinical Practice

inVentiv Health Consulting conducted a survey of 85 physicians (oncologists, n = 30; and non-oncologists, n = 55) in February 2017 to explore the views of physicians regarding the role of biomarkers and companion diagnostics in clinical practice.

BioPharmaceutical Medical Device
See All
Advertisement
UsernamePublicRestriction

Register